Aurinia Pharmaceuticals (AUPH) Current Deferred Revenue (2017 - 2026)
Aurinia Pharmaceuticals (AUPH) posted Current Deferred Revenue of $10.59 million for Q2 2026, up 92.6% from $5.5 million a year earlier and up 110.3% from the prior quarter.
Powered by 
Analysis
Aurinia Pharmaceuticals (AUPH) Current Deferred Revenue (2017 - 2026) Analysis & Trends
At the end of FY2025, Aurinia Pharmaceuticals' Current Deferred Revenue came in at $3.72 million, down 66.2% from FY2024.
- Annual Current Deferred Revenue shows a four-year compound annual growth rate of 110.4% (FY2021 to FY2025).
- In prior years, Aurinia Pharmaceuticals' Current Deferred Revenue was $11 million in FY2024 (+128.6%), $4.81 million in FY2023 (+52.9%), $3.15 million in FY2022 and $190,000 in FY2021.
- The Q2 2026 figure stands as the highest quarterly Current Deferred Revenue since Q4 2024.
- On a year-over-year basis, Current Deferred Revenue increased in five of the last eight quarters, with growth averaging 22.9%.
- The strongest year-over-year quarter for Current Deferred Revenue in the past five years was Q4 2024, with growth of 128.6%; the weakest was Q4 2025, with a decline of 66.2%.
- According to Business Quant data, Current Deferred Revenue for the three prior quarters was $5.04 million (Q1 2026), $3.72 million (Q4 2025) and $4.6 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Aurinia Pharmaceuticals | 2.15 Bn | 580.05 Mn | 76.67 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.59 Mn |
| Mar 31, 2026 | 5.04 Mn |
| Dec 31, 2025 | 3.72 Mn |
| Sep 30, 2025 | 4.60 Mn |
| Jun 30, 2025 | 5.50 Mn |
| Mar 31, 2025 | 4.59 Mn |
| Dec 31, 2024 | 11.00 Mn |
| Sep 30, 2024 | 4.30 Mn |
| Jun 30, 2024 | 4.37 Mn |
| Mar 31, 2024 | 4.91 Mn |
| Dec 31, 2023 | 4.81 Mn |
| Sep 30, 2023 | 4.66 Mn |
| Jun 30, 2023 | 3.23 Mn |
| Mar 31, 2023 | 3.16 Mn |
| Dec 31, 2022 | 3.15 Mn |
| Dec 31, 2021 | 190,000.00 |
| Dec 31, 2017 | 560,000.00 |
API Access
Aurinia Pharmaceuticals Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=AUPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "AUPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=AUPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();